相关实验视频
Updated: Jun 17, 2025

08:56
Derivation of Glial Restricted Precursors from E13 mice
Published on: June 20, 2012
11.3K
遗传白质疾病的质起源
Anjana Sevagamoorthy1, Adeline Vanderver1,2, Jamie L Fraser3
1Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
Cold Spring Harbor perspectives in biology
|August 12, 2024
概括
遗传性白质疾病 (IWMDs) 很少见,但很常见,每7500名新生儿中就有1名患有这种疾病. 这些遗传性白血脑病的早期诊断和管理对于预防严重表现和改善结果至关重要.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 遗传性白质疾病 (IWMDs) 代表了一组多样化的中枢神经系统 (CNS) 疾病,影响质细胞 (白血病) 或其他中枢神经系统细胞 (遗传性白血病).
- 这些罕见的疾病大约影响7500名新生儿中的1名,其特点是显著的表型和基因型异质性.
- 诊断方面的挑战,包括延迟或误诊,是常见的,因为IWMDs的临床表现不同.
研究的目的:
- 突出IWMD的诊断挑战和临床异质性.
- 强调早期识别和管理的重要性,以预防严重的次要表现.
- 探索新兴疗法的潜力及其对遗传性和获得性白质疾病的影响.
主要方法:
- 审查关于IWMD的现有文献,包括遗传分类,临床表现和诊断标准.
- 对当前治疗策略的分析,包括针对特定IWMD的基因疗法试验,如甲色白血病 (MLD) 和上腺白血病 (ALD).
- 探索潜在的治疗点,包括质细胞和外周免疫系统.
主要成果:
- 由于其复杂和多样化的症状,IWMD经常被误诊或被诊断迟到.
- 早期检测和主动管理可以预防与IWMD相关的危及生命的二次并发症.
- 对于MLD和ALD的基因治疗有前途的进展表明,有可能减缓或阻止疾病的进展.
- 向质细胞或免疫系统可能为IWMD和获得的白质疾病提供新的治疗途径.
结论:
- 及时诊断和干预对于管理IWMD和减轻其严重后果至关重要.
- 新兴疗法,特别是基因疗法,对治疗特定的IWMD和潜在地改变疾病轨迹显示出希望.
- 了解IWMD的机制可能会为更广泛的白质条件带来新的治疗方法.
相关概念视频
Glial Cells
86.7K
Overview
86.7K
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K
Neurogenesis and Regeneration of Nervous Tissue
750
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
750
Nervous Tissue: Myelin
2.5K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
2.5K
Nervous Tissue: Glial Cells
2.8K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
2.8K

